Development and characterization of a novel in vivo model of carcinoid syndrome
about
Generation of Pet1210-Cre transgenic mouse line reveals non-serotonergic expression domains of Pet1 both in CNS and peripheryComplications from carcinoid syndrome: review of the current evidenceVEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis.An analysis of trends and growth factor receptor expression of GI carcinoid tumorsSerotonin reverts age-related capillarization and failure of regeneration in the liver through a VEGF-dependent pathway.The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional studyThe effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BONThe vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1.Dual inhibition of PI3K and mTOR signaling pathways decreases human pancreatic neuroendocrine tumor metastatic progression.Gastro-Enteropancreatic Neuroendocrine Tumor Cell Dynamics in Liver Microvasculature.A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases.Telotristat ethyl: a new option for the management of carcinoid syndrome.Serotonin and the 5-HT7 receptor: the link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors.Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo properties.When best evidence is rarer than the disease.Neuroendocrine tumors and fibrosis: An unsolved mystery?Carcinoid-syndrome: recent advances, current status and controversies.
P2860
Q27316205-34B003A7-733D-447B-A4F1-A1BB34C89766Q28068096-DC2DBFB6-9C12-4A28-A4D2-863E98EE5105Q33926020-16BB5CC5-57B1-43E2-AE09-502C6AA11900Q33985773-EFF087FD-F813-4CCC-A3D8-3284A5281738Q34582994-8A40DCBC-B0A6-4BF9-A937-C073606D16C3Q34998790-0D4C58AA-B3EA-4CD2-8AC2-48A63CD8BF82Q35178600-C695FBC8-2F0E-4D99-B1E5-BCD42B187A66Q36682884-05AA14B2-08EC-4F0D-9D85-CA0F78591587Q37395920-3AF1A3CB-FD4A-446C-BA3B-A7FED9C334C4Q38881191-17235497-C114-49BA-A3DA-A03A8EB12CC6Q38970716-2A45093D-4136-448E-997A-5F79AD3E8441Q39000212-DD467D43-556C-4131-8D85-C2A7611A35DDQ39167927-6F1953A2-9150-4D36-BC0A-775E388D5209Q39523791-D5642CBB-5438-427F-B51E-4734AE25BD3BQ46541105-EAD327B7-6646-4C67-83BB-2D679E5F87EAQ47720153-2FE98141-A35E-47FA-8818-905464574BCEQ50094023-784D4EDE-139F-4935-BECF-ED0C75648E06
P2860
Development and characterization of a novel in vivo model of carcinoid syndrome
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Development and characterization of a novel in vivo model of carcinoid syndrome
@ast
Development and characterization of a novel in vivo model of carcinoid syndrome
@en
type
label
Development and characterization of a novel in vivo model of carcinoid syndrome
@ast
Development and characterization of a novel in vivo model of carcinoid syndrome
@en
prefLabel
Development and characterization of a novel in vivo model of carcinoid syndrome
@ast
Development and characterization of a novel in vivo model of carcinoid syndrome
@en
P2093
P2860
P1476
Development and characterization of a novel in vivo model of carcinoid syndrome
@en
P2093
B Mark Evers
Courtney M Townsend
Gilberto Defreitas
L Andy Chen
Lindsey N Jackson
Paul J Boor
Scott R Silva
W Lane Stafford
P2860
P304
P356
10.1158/1078-0432.CCR-08-2346
P407
P577
2009-03-31T00:00:00Z